April 29 (Reuters) - The U.S. Centers for Medicare & Medicaid Services said on Wednesday it has extended key application ...
The Medicaid Drug Rebate Program and the 340B Drug Pricing Program are generally understood as separate efforts to promote drug affordability—one by directly subsidizing low-income patients through ...
The Centers for Medicare and Medicaid Services is extending the application deadline for drug manufacturers to apply to the ...
Add Yahoo as a preferred source to see more of our stories on Google. U.S. flag and medicines are seen in this illustration taken, June 27, 2024. REUTERS/Dado Ruvic/Illustration/File Photo (Reuters) ...
On December 19, 2025, the Centers for Medicare & Medicaid Services (CMS) released GLOBE (Global Benchmark for Efficient Drug Pricing Model) and GUARD (Guarding U.S. Medicare Against Rising Drug Costs) ...
The Center for Medicare and Medicaid Innovation (CMMI)[1] recently released information about three new models aimed at testing alternative calculations for manufacturer rebates, to ensure net drug ...
The Centers for Medicare and Medicaid Services (CMS) said Wednesday that state Medicaid programs must cover pharmaceuticals approved under FDA’s accelerated approval (AA) pathway. “In summary, this ...
WASHINGTON — The government on Thursday unveiled a new program to cut prescription drug costs for Medicaid patients by tying prices to those paid in other countries. The announcement follows previous ...
The U.S. government on Thursday unveiled a new program to cut prescription drug costs for Medicaid patients by tying prices to those paid in other countries. The announcement follows previous ...
The U.S. government on Thursday unveiled a new program to cut prescription drug costs for Medicaid patients by tying prices to those paid in other countries. The announcement follows previous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results